Pfizer Independent Education Grants
Request for Proposals (RFP)

Patient Education and Support for theManagement of Migraine
Competitive Grant Program – Pfizer Internal Review ProcessOverview
Patient education about migraine empowers individuals, helps
diagnose those who are currently undiagnosed, improves treatment
outcomes, and enhances overall quality of life for those affected bymigraine. However, due to multiple factors including social/public,
structural and self-stigma, migraine education is lacking for people
living with migraine. There is a need for educational programs that
increase availability and accessibility of current, evidence-based
information and promote informed decision-making and active
participation in one’s migraine care.

Geographic Scope
GlobalProject Types and Area of Interest
This competitive grant program seeks to support projects focused on
addressing patient education on disease awareness, diagnosis,treatment, adherence, and general management of patients livingwith migraine.

Key Milestones• Application submission deadline: August 15, 2023
• Anticipated decision notification date: September 2023

Funding Range and Project Length
Grant range expected to be from $10,000 to $150,000 USD.
Maximum project length is 2 years.

I. Eligibility
Geographic Scope:•GlobalApplicant Eligibility Criteria•••••

Only organizations are eligible to receive grants, not individuals or medical practice groups.
Organizations representing patients and caregivers are encouraged to apply. In addition, professional
associations, medical societies and other entities with a mission related to patient education andsupport for the management of migraine may apply.
If the project involves multiple departments within an institution and/or between different institutions /organizations / associations, all departments and/or institutions must have a relevant role and therequesting organization must have a key role in the project.
The applicant must be the project/program lead or an authorized designee of such individual (e.g.,project/program lead’s grant coordinator). The project/program lead must be an employee orindependent contractor of the requesting organization.
Requesting organization must be legally able to receive award funding directly from Pfizer Inc. We
strongly recommend that applicants confirm this with their organization or institution prior to submitting
an application. Grants awarded to organizations that are subsequently found to be unable to accept
funding directly from Pfizer Inc. may be subject to rescission.

II. Requirements
Date RFP Issued:•July 5, 2023

Clinical Area:•Migraine

General Area of Interest for this RFP:
•Patient education about migraine empowers individuals, helps diagnose those who are currentlyundiagnosed, improves treatment outcomes, and enhances overall quality of life for those affected bymigraine. However, due to social/public, structural and self-stigma, migraine education is severely
lacking for people living with migraine. There is a need for educational programs that increaseavailability and accessibility of current, evidence-based information and promote informed decisionmaking and active participation in one’s migraine care. Projects that will be considered for support will
focus on addressing patient education on disease awareness, diagnosis, treatment, adherence, andgeneral management of patients living with migraine. Pfizer is interested in educational initiatives that2encompass the following:•Patient focused initiatives to educate, empower, and support patients living with migraine•Patient educational resources about migraine disease, including but not limited to the following:
oEpidemiologyoPathophysiology (i.e., a type of neurological disorder, migraine threshold theory)oContributing factors and triggers (e.g., stress, insomnia, physical inactivity)oBiopsychosocial approach to treatment (e.g., pharmacotherapy, headache monitoring/trigger
management, relaxation, biofeedback, cognitive behavioral interventions, lifestylemodifications, community support)oMedication overuse/”adaptation” headacheooSymptomology across migraine phases and diagnosis
Comorbid conditions (e.g., medical diagnoses, mental health conditions)oMigraine chronification

oParenting with migraineooo

Migraine and pregnancy/post-partum
Understanding and addressing migraine-related stigma
Finding community support/becoming an advocate•

Tools to help with adherence to pharmacotherapy and other interventions•

Resources to help patients communicate with caregivers, family and friends about migraine•

Resources to help patients communicate with their healthcare providers about migraine•

Resources to help patients navigate migraine in the workplace•

Initiatives that promote diversity, equity, and inclusion in patient education and migraine management,including but not limited to the following:oResources geared toward patients in search of headache care adversely affected by social
determinants of health (e.g., race/ethnicity, low health literacy, lack of access to physiciancare, limited insurance/financial coverage, etc.)

oDissemination strategies that increase reach to underserved and marginalized communities
and demographics

It is not our intent to support clinical research projects. Projects evaluating the efficacy of therapeuticor diagnostic agents will not be considered.

Target Audience:•Patients, caregivers, and organizations representing patients and caregivers

3Expected Approximate Monetary Range of Grant Applications:•••Individual projects requesting up to $150,000 USD will be considered. The estimated total available
budget related to this RFP is $500,000 USD.
In order to be competitive, projects that will have a more limited patient reach such as a one regional
community or a smaller country should have a lower grant request amount – in the $10,000 to$30,000 USD range
Award amounts include direct costs, institutional overhead costs (capped at 28% per Pfizer policy),
and indirect costs.

Key Dates:•••••

RFP release date: July 5, 2023
Grant Application due date: August 15, 2023
Please note the deadline is 23:59 Eastern Standard Time (e.g., New York, GMT -5).
Anticipated Grant Award Notification Date: September 2023
Grants will be distributed following a fully executed agreement.
Anticipated Project Start Date: November 2023 (2-year maximum project length, projects may be
shorter than 2-years)

How to Submit:
Note: Please read this section carefully since applications submitted not following these instructions will
not be accepted and will be cancelled.
• Please go to www.cybergrants.com/pfizer/knowledge and sign in. First-time users should click “Createyour password”. [Note: there are individual portals for each grant application type. Please be sure touse the URL above.]• Click the “Start A New Knowledge Gap Application" button.
• In the application:• For the question “What type of request are you submitting?” select Response to a Request forProposal (RFP)• For the question “Are you replying to a Request for Proposal (RFP) as part of the Competitive
Grant Program?” select Yes• Select the following Competitive Grant Program Name: 2023 IM G Migraine Patient Education• Select the following Primary Area of Interest: Migraine• Requirements for submission:
Complete all required sections of the online application and upload your project proposal (seeAppendix) in the General RFP Submission field.
• If you encounter any technical difficulties with the website, please click the “Technical Questions” linkat the bottom of the page.
IMPORTANT: Be advised applications submitted after the due date will not be reviewed.

Questions:•If you have questions regarding this RFP, please direct them in writing to the Grant Officer, Jessica
Romano (Jessica.Romano@pfizer.com), with the subject line: “2023 IM G Migraine PatientEducation.”

Grant Agreements:

4

•
•

•
•

If your grant is approved, your institution will be required to enter into a written grant agreement withPfizer. Please click here to view the core terms of the agreement.
Under Pfizer's competitive grant program, modifications to grant agreements will not be reviewed
unless a genuine conflict exists as between applicable law and the terms of the relevant grantagreement. Applicant is encouraged to share the core terms with counsel for approval prior tosubmitting an application.
Except where prohibited by applicable law and, in any case, subject to review by Pfizer Legal,payment of grant funding may only be paid to the grantee organization.
This RFP is supported by Pfizer Inc. and, if approved, payment will be sent from the United States.

Review and Approval Process:•Grant requests received in response to a general RFP are reviewed by Pfizer to make final grantdecisions.

Mechanism by which Applicants will be Notified:••

All applicants will be notified via email by the dates noted above.
Applicants may be asked for additional clarification during the review period.

About Pfizer Global Medical Grants
Pfizer Global Medical Grants (GMG) supports the global healthcare community’s independent initiatives (e.g.,research, quality improvement, or education) to improve patient outcomes in areas of unmet medical needthat are aligned with Pfizer’s medical and/or scientific strategies.
Pfizer’s GMG competitive grant program involves a publicly posted general Request for Proposal (RFP) thatprovides detail regarding a general area of interest, sets timelines for review and approval, and uses aninternal Pfizer review process to make final grant decisions. Organizations are invited to submit an application
addressing the knowledge gaps as outlined in the specific RFP.
For all independent medical education grants, the grant requester (and ultimately the grantee) is responsible
for the design, implementation, and conduct of the independent initiative supported by the grant. Pfizer mustnot be involved in any aspect of project development, nor the conduct of the independent education program.

5Appendix
General RFP Submission Requirements
Applications will be accepted via the online portal listed in the How to Submit section. Project Proposals
should be single-spaced using Calibri 12-point font and 1-inch margins. Note there is a 15-page limit
exclusive of references. When uploading your Project Proposal please ensure it addresses the following
sections:

Goals and Objectives••

Briefly state the overall goal of the project.
List the objectives you plan to meet with your project, in terms of learning and expected outcomes.

Needs Assessment for the Project•

Include a description of your organization’s needs assessment for this proposed project which may
include a quantitative baseline data summary, initial metrics, or a project starting point (please cite dataon gap analyses or relevant patient-level data that informs the stated objectives) in your target area.

Target Audience•Describe the primary audience(s) targeted for this project. Indicate whom you believe will directly benefit
from the project outcomes. Describe the overall population size as well as the size of your sample
population.

Project Design and Methods•

Describe the planned project, the educational approach, and the way the planned methods address theestablished need.

Innovation•

Explain what measures you have taken to assure that this project is original and does not duplicate otherprojects or materials already developed. Describe how this project builds upon existing work, pilot
projects, or ongoing projects developed either by your institution or other institutions.

Evaluation and Outcomes•

In terms of the metrics used for the needs assessment, describe how your organization will determine if
the gap was addressed for the target group. Identify the sources of data your organization anticipatesusing to make the determination. Describe how your organization is expected to collect and analyze thedata. Explain the method used to control for other factors outside this project (e.g., use of a control groupor comparison with baseline data). Quantify the amount of change expected from this project in terms thetarget audience. Describe how your organization will determine if the target audience was fully engaged
in the project.

Dissemination Plan•Describe how the project may have extended benefit beyond the grant. Will the teaching materials be
made available to others to use? Will there be tools or resources that are made publicly available
beyond the initial project. Describe how the project outcomes might be broadly disseminated.

Anticipated Project Timeline•

Provide an anticipated timeline for your project including project start/end dates.

6

Additional Information•

If there is any additional information you feel Pfizer should be aware of concerning the importance of thisproject, please summarize here.

Organization Detail•Describe the attributes of the institutions / organizations / associations that will support and facilitate theexecution of the project and the leadership of the proposed project. Articulate the specific role of eachpartner in the proposed project.

Budget Detail••Please include a budget narrative that describes in greater detail the line items specified in the budget
submitted within the application.
While estimating your budget please keep the following items in mind:• Independent Medical Education Grants awarded by GMG cannot be used to purchase therapeuticassets (prescription or non-prescription).
• Overhead rates of up to 28% of the total proposed project budget may be supported by Pfizer.
Please click here for details.

7